AzTrials
AzTrials

Low Back PainNCT03970486

Effects of Two Different Dry-Needling Techniques for Low Back Pain

A study testing Dry needling in people with Low Back Pain, run by Texas Woman's University at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Although dry-needling with or without manipulation has shown to be a useful technique to reduce pain in patients with low back pain (LBP), it is unclear which of these two dry-needling techniques would have a greater effect on the lumboscaral multifidus (LM) muscle activation, which is essential in LBP rehabilitation. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Low Back Pain
What is being tested?
Dry needling
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteUnited States
Study dates
22 Sep 2017to 31 Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • English-speaking adults and are 18 years of age or older.
  • For asymptomatic healthy adults: no existing low back pain (LBP) and no LBP in the past 6 months.
  • For individuals with LBP: existing LBP near the L5-S1 level with an average pain intensity score ≥ 2/10 in the past 24 hours (numeric pain rating scale of 0-10, 0 being no pain, 10 being unbearable pain)
  • Exclusion Criteria (for both the asymptomatic healthy and patients with low back pain groups) :
  • Bleeding disorders (e.g. hemophilia)
  • Use of anti-coagulants (e.g. Coumadin)
Show all 11Show fewer
  • Previous low back surgery, systemic joint disease (e.g. rheumatoid arthritis)
  • Cancer of the lower quadrant,
  • Neurological disorders
  • Allergic reaction to adhesive tape
  • Inability to obtain testing positions (prone lying)

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Sharon Wang-Price, PhD contact

2146897715

swang@twu.edu

United States1 site, 1 recruiting
  • Texas Woman's University

    Dallas, Texas, 75235

    Sharon Wang-Price, PhD, 214-689-7715, swang@twu.edu

    Recruiting

Other trials in United States

About this study

Official title: Effects of Two Different Dry-Needling Techniques on Lumbar Multifidus Muscle Activation and Pressure Pain Threshold in Healthy Adults and Patients With Low Back Pain

Although dry-needling with or without manipulation has shown to be a useful technique to reduce pain in patients with low back pain (LBP), it is unclear which of these two dry-needling techniques would have a greater effect on the lumboscaral multifidus (LM) muscle activation, which is essential in LBP rehabilitation. Therefore, the purposes of the study are: 1) to investigate whether or not dry-needling would change muscle activity of the LM muscles in asymptomatic healthy adults and in individuals with LBP, respectively, and 2) to compare the effects of two dry-needling techniques on LM muscle activation and pressure pain threshold (PPT) in asymptomatic healthy adults and individuals with LBP, respectively.

Read the detailed description

PARTICIPANTS

Participants will be recruited from local communities, including but not limited to Texas Woman's University (TWU) via flyers. The flyers will be posted at the TWU - Dallas campus, and Texas Physical Therapy Specialist - Dallas where one of the principal investigators, Zach Couch, works, and other community centers with approval.

Participants who are interested in taking part in the study will be asked to call the investigators to schedule an appointment. The consent form will be presented at the beginning of the appointment.

Eligible participants are English-speaking adults and are 18 years of age or older. Additional criteria for asymptomatic healthy adults include no existing LBP and no LBP in the past 6 months. Additional criteria for symptomatic participants include existing LBP near the L5-S2 level with an average pain intensity score ≥ 2/10 in the past 24 hours (numeric pain rating scale of 0-10, 0 being no pain, 10 being unbearable pain).

Exclusion criteria for all participants include bleeding disorders (e.g. hemophilia), use of anti-coagulants (e.g. Coumadin), previous low back surgery, systemic joint disease (e.g. rheumatoid arthritis), cancer of the lower quadrant, neurological disorders, allergic reaction to adhesive tape, or inability to obtain the testing position (prone lying).

OUTCOME MEASURES

  1. Electromyographic (EMG) activity A Delsys EMG system with 2 wireless surface electrodes (Delsys Inc., Natick, MA) will be used to obtain muscle activities of the LM, one at the L5 level, and the other at the S2 level. The bandwidth of the EMG system will be set at 20 to 450 Hz with a gain of 1,000. The EMG signal will be recorded at a sampling rate of 2,000 Hz. Each surface electrode has a built-in reference electrode.
  2. Pressure Pain Threshold (PPT) A hand-held computerized pressure algometer (Medoc ltd., Ramat Yishai, Israel) will be used to determine the PPT on the two most tender points corresponding to the two EMG electrode sites. The algometer consists of a 1-cm2 round tip that will be pressed vertically on the target locations of the muscle. To provoke the patient's pain or discomfort, pressure will be increased at a rate of 40 kPa/sec until the participant feels pain as indicated by pressing a patient safety unit. The limit of pressure threshold will be set at 800 kPa, meaning that a pressure exceeding 800 kPa will be cut off to minimize tissue damage. If the participant does not push the button at 800 kPa, a value of 800 is used as the threshold value.

PROCEDURE

After participants are informed of the risks, benefits and procedures of the study, they will be asked to sign a written consent form approved by the TWU Institutional Review Board - Dallas. Eligible participants will be asked to complete an intake form to collect their demographic data (age, gender, height, weight, occupation, hand dominance), past medical history, and questions related to their past history of pain if applicable (onset, injury mechanism if any, location, duration, type, and nature). The symptomatic participants also will be asked to rate their pain intensity at present, at worst, and at best in the past 24 hours using the NPRS. Participants who exhibit any of the exclusion criteria will be excluded from the study. Once the participants is determined to be eligible for the study, they will be asked to complete the Modified Oswestry Low Back Pain Disability Questionnaire (OSW), which will be used to determine their perceived disability and functional limitations due to LBP.

Next, the EMG activity and PPTs will be collected from the painful side of the participants with LBP and the right side of the asymptomatic participants. When the symptomatic participants have bilateral LBP, the EMG activity and PPTs will be collected from the most painful side. If both sides are equally painful, a coin toss was performed to select the side (heads for the right side, tails for the left side).

During the EMG and PPT testing, participants will be asked to lie in a prone position on an examination table with their arms on the sides. A pillow was placed under the participant's abdomen to flatten the lumbar lordotic curve and an inclinometer will be placed on the lumbosacral junction to ensure the lumbar curve ≤10°. The spinous processes of the L1-S2 and posterior superior iliac spine (PSIS) will be be identified by palpation and marked with a skin marker.

  1. EMG Activity Recording To prepare for EMG recording, each participant's skin over the LM muscles (between L4-S2) will be cleaned with alcohol and, if needed, excessive hair will be shaved using a disposable razor. Adhesive tape will be used to affix two wireless EMG electrodes to the skin over the LM muscles, one at the L5 level and the other at the S2 level. Following the recommendation by the Surface ElectroMyoGraphy for the Non-Invasive Assessment of Muscles (SENIAM) project (http://www.seniam.org/), the L5 electrodes were placed at the level of the L5 spinous process (i.e. about 2 - 3 cm from the midline) and aligned with a line from the posterior superior iliac spine (PSIS) to the interspace between the L1 and L2 spinous process. The S2 electrode was placed medial to the PSIS. During EMG recording, participants will be asked to abduct the contralateral shoulder and flex the contralateral elbow to approximately 90° while holding a 1.5 or 2 lb. hand weight. A participant will hold a 1.5 lb. hand weight if his/her body weight is less than 175 lbs., and hold a 2 lb. hand weight if his/her body weight is more than 175 lbs. First, the EMG activity of the LM was recorded during a contralateral arm lift (Figure 1a), which has been shown to best elicit LM muscle activation. A verbal instruction will be given before the participant performed the contralateral arm lift: "Breathe normally. Without moving your pelvis or spine, raise your arm above the table". Each participant will be given one practice trial before EMG recording begins, and then perform a 5-second contralateral arm lift five times. If a participant demonstrate difficulty in holding for 5 seconds, the participant will be allowed to hold for a shorter period of time, but a minimum of 3 seconds. Next, two trials of maximal voluntary isometric contraction (MVIC) of the LM muscles will be obtained by asking the participant to perform a contralateral arm lift while the investigator applies a steady downward force on the elbow opposite the side of the tested LM muscles (Figure 1b). Two 5-second MVIC trials will be recorded with a minimum of a 1-min rest between the two trials.
  2. Pressure-pain Threshold (PPT) Testing For PPT testing, participants will be instructed to stop the test as soon as the "pressure" becomes "uncomfortable or painful" and will be instructed not to allow the "uncomfortable or painful sensation" to continue. A standardized instruction will be given to each participant prior to PPT testing: "This is a patient safety unit. (The investigator will show the participant the unit). Please hold it with the hand opposite of the testing side. When the testing begins, we will push the rounded tip of this instrument (point to the pressure algometer) into this muscle (point to the testing point) and you will feel a "pressure-like" sensation. As soon as this pressure-like sensation becomes painful or uncomfortable to you, push the green button of the patient safety unit immediately. By pushing the green button, you can stop the testing. Do not let this painful or uncomfortable sensation continue." Four trials will be performed on each of two tender points.
  3. Interventions Three investigators are experienced physical therapists in treating patients with LBP. All are certificated manual therapists and fellows with the America Academy of Orthopedic Manual Physical Therapy. In addition, one investigator has practiced dry-needling for the past 12 years and the other two have practiced dry-needling for the past 5 years. Before data collections, the two dry-needling intervention techniques will be standardized so that all three investigators will be able to administer either one of the two dry-needling techniques when they are needed. In addition, the research assistants who will collect the outcome measures (EMG activity and PPT) will be blinded to the type of the dry-needling techniques. Once baseline outcome measures are collected, each participant will be randomly assigned into one of the dry-needling intervention techniques, with and without needle manipulation. The insertion of the needles will be the same for both techniques. A sterile, disposable 0.30 mm x 50 mm or 0.30 x 60 mm solid filament needle (Seirom Corp., Shizuoka, Japan) will be inserted into the bilateral LM muscles approximately 1.5 cm lateral to the L5 or S2 spinous process level. The needling sites are corresponding to the EMG and PPT testing points. The needles used in the study will be exactly the same needles used for acupuncture. After piercing the skin, the needle will be directed toward the spinous process in a slight inferior-medial angle (approximately 20 °). This angle was chosen because the needle will be stopped by the bony laminia part of vertebra to ensure a safe intervention and to standardize the depth of the needle insertion. For the needle manipulation technique, the needle will be pulled in and out (sparrow pecking) and redirected in small angles (coning) for 5-10 seconds. For the non-needling manipulation technique, the four needles will stay (in situ) for 10 minutes after the insertion of the needle. The investigator who administers the dry needling interventions will wear gloves during the intervention and will dispose of the used needles in a sharp container. Because needles will be used in the study, universal precautions will be followed throughout the data collection.
  4. Reassessment

Immediately after the dry-needling intervention, the two outcome measures (EMG activity and PPTs) will be collected again. Each participant will also be asked about any presence of common adverse symptoms, including increased pain, nausea, dizziness and fatigue. If bleeding occurs, the participant will be informed of the occurrence. All participants will also be asked to avoid strenuous trunk activity or exercises for the following week. All participants will be scheduled to return in approximately 1 week for the final reassessment, including EMG activity and PPT testing. After return, all participants will be re-questioning about whether they experience any adverse symptoms after dry-needling.

Conditions
Low Back Pain
Being tested
Dry needling
Medical subject headings
Low Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dry needlingProcedure or surgery

    For the needle manipulation technique, the needle will be pulled in and out (sparrow pecking) and redirected in small angles (coning) for 5-10 seconds. For the in situ technique, the needles will stay (in situ) in the left and right lumbar multifidus muscles for 10 minutes after the insertion of the needle.

Study groups in NCT03970486
Study groupRoleWhat they receive
Needle ManipulationActive comparatorParticipant will receive dry needling intervention with manipulation.
Receives: Procedure: Dry needling
In SituActive comparatorParticipant will receive dry needling intervention without manipulation.
Receives: Procedure: Dry needling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change of Muscle activity

    An electroencephalographic (EMG) system with 4 wireless surface electrodes will be used to obtain muscle activities of the right and left lumbar multifidus muscles at the L5 and S2 levels.

    Measured: Before intervention, immediately after intervention and one week after intervention

  2. Change of Pressure pain threshold

    A hand-held computerized pressure algometer will be used to determine the pressure pain threshold on the same 4 sites of EMG recording.

    Measured: Before intervention, immediately after intervention and one week after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 May 2019
  2. Study start22 Sep 2017
  3. Primary completion31 Dec 2019 (estimated)
  4. Study completion31 Dec 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be assigned into two dry needling treatment groups.
Masking
None (open label)
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03970486
Sponsor's protocol ID
19750
Status last verified
May 2019
First submitted
22 Sep 2017
Last updated
31 May 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Wang-Price S, Zafereo J, Couch Z, Brizzolara K, Heins T, Smith L. Short-term effects of two deep dry needling techniques on pressure pain thresholds and electromyographic amplitude of the lumbosacral multifidus in patients with low back pain - a randomized clinical trial. J Man Manip Ther. 2020 Dec;28(5):254-265. doi: 10.1080/10669817.2020.1714165. Epub 2020 Jan 17.

    PubMed 31960773

Questions about this trial

What is this clinical trial studying?

A study testing Dry needling in people with Low Back Pain, run by Texas Woman's University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 31 May 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Sharon Wang-Price, PhD (2146897715, swang@twu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change of Muscle activity (time frame: Before intervention, immediately after intervention and one week after intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03970486, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 May 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in